Cargando…

Plasma Concentrations of Inflammatory Cytokines Rise Rapidly during ECMO-related SIRS due to the Release of Pre-formed Stores in the Intestine

BACKGROUND: Extracorporeal membrane oxygenation (ECMO) is a life-saving support system used in neonates and young children with severe cardiorespiratory failure. Although ECMO has reduced mortality in these critically-ill patients, almost all patients treated with ECMO develop a systemic inflammator...

Descripción completa

Detalles Bibliográficos
Autores principales: McILwain, Britt, Timpa, Joseph, Kurundkar, Ashish R., Holt, David W., Kelly, David R., Hartman, Yolanda, Neel, Mary Lauren, Karnatak, Rajendra K., Schelonka, Robert L., Anantharamaiah, G. M., Killingsworth, Cheryl R., Maheshwari, Akhil
Formato: Texto
Lenguaje:English
Publicado: 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2799549/
https://www.ncbi.nlm.nih.gov/pubmed/19901912
http://dx.doi.org/10.1038/labinvest.2009.119
_version_ 1782175802483277824
author McILwain, Britt
Timpa, Joseph
Kurundkar, Ashish R.
Holt, David W.
Kelly, David R.
Hartman, Yolanda
Neel, Mary Lauren
Karnatak, Rajendra K.
Schelonka, Robert L.
Anantharamaiah, G. M.
Killingsworth, Cheryl R.
Maheshwari, Akhil
author_facet McILwain, Britt
Timpa, Joseph
Kurundkar, Ashish R.
Holt, David W.
Kelly, David R.
Hartman, Yolanda
Neel, Mary Lauren
Karnatak, Rajendra K.
Schelonka, Robert L.
Anantharamaiah, G. M.
Killingsworth, Cheryl R.
Maheshwari, Akhil
author_sort McILwain, Britt
collection PubMed
description BACKGROUND: Extracorporeal membrane oxygenation (ECMO) is a life-saving support system used in neonates and young children with severe cardiorespiratory failure. Although ECMO has reduced mortality in these critically-ill patients, almost all patients treated with ECMO develop a systemic inflammatory response syndrome (SIRS) characterized by a ‘cytokine storm’, leukocyte activation, and multisystem organ dysfunction. We used a neonatal porcine model of ECMO to investigate whether rising plasma concentrations of inflammatory cytokines during ECMO reflect de novo synthesis of these mediators in inflamed tissues, and therefore, can be used to assess the severity of ECMO-related SIRS. METHODS: Three-week-old previously-healthy piglets were subjected to venoarterial ECMO for up to 8 hours. SIRS was assessed by histopathological analysis, measurement of neutrophil activation (flow cytometry), plasma cytokine concentrations (enzyme immunoassays), and tissue expression of inflammatory genes (polymerase chain reaction/western blots). Mast cell degranulation was investigated by measurement of plasma tryptase activity. RESULTS: Porcine neonatal ECMO was associated with systemic inflammatory changes similar to those seen in human neonates. TNF-α and interleukin-8 (IL-8) concentrations rose rapidly during the first 2 hours of ECMO, faster than the tissue expression of these cytokines. ECMO was associated with increased plasma mast cell tryptase activity, indicating that increased plasma concentrations of inflammatory cytokines during ECMO may result from mast cell degranulation and associated release of preformed cytokines stored in mast cells. CONCLUSIONS: TNF-α and IL-8 concentrations rose faster in plasma than in the peripheral tissues during ECMO, indicating that rising plasma levels of these cytokines immediately following the initiation of ECMO may not reflect increasing tissue synthesis of these cytokines. Mobilization of preformed cellular stores of inflammatory cytokines such as in mucosal mast cells may play an important pathophysiological role in ECMO-related SIRS.
format Text
id pubmed-2799549
institution National Center for Biotechnology Information
language English
publishDate 2009
record_format MEDLINE/PubMed
spelling pubmed-27995492010-07-01 Plasma Concentrations of Inflammatory Cytokines Rise Rapidly during ECMO-related SIRS due to the Release of Pre-formed Stores in the Intestine McILwain, Britt Timpa, Joseph Kurundkar, Ashish R. Holt, David W. Kelly, David R. Hartman, Yolanda Neel, Mary Lauren Karnatak, Rajendra K. Schelonka, Robert L. Anantharamaiah, G. M. Killingsworth, Cheryl R. Maheshwari, Akhil Lab Invest Article BACKGROUND: Extracorporeal membrane oxygenation (ECMO) is a life-saving support system used in neonates and young children with severe cardiorespiratory failure. Although ECMO has reduced mortality in these critically-ill patients, almost all patients treated with ECMO develop a systemic inflammatory response syndrome (SIRS) characterized by a ‘cytokine storm’, leukocyte activation, and multisystem organ dysfunction. We used a neonatal porcine model of ECMO to investigate whether rising plasma concentrations of inflammatory cytokines during ECMO reflect de novo synthesis of these mediators in inflamed tissues, and therefore, can be used to assess the severity of ECMO-related SIRS. METHODS: Three-week-old previously-healthy piglets were subjected to venoarterial ECMO for up to 8 hours. SIRS was assessed by histopathological analysis, measurement of neutrophil activation (flow cytometry), plasma cytokine concentrations (enzyme immunoassays), and tissue expression of inflammatory genes (polymerase chain reaction/western blots). Mast cell degranulation was investigated by measurement of plasma tryptase activity. RESULTS: Porcine neonatal ECMO was associated with systemic inflammatory changes similar to those seen in human neonates. TNF-α and interleukin-8 (IL-8) concentrations rose rapidly during the first 2 hours of ECMO, faster than the tissue expression of these cytokines. ECMO was associated with increased plasma mast cell tryptase activity, indicating that increased plasma concentrations of inflammatory cytokines during ECMO may result from mast cell degranulation and associated release of preformed cytokines stored in mast cells. CONCLUSIONS: TNF-α and IL-8 concentrations rose faster in plasma than in the peripheral tissues during ECMO, indicating that rising plasma levels of these cytokines immediately following the initiation of ECMO may not reflect increasing tissue synthesis of these cytokines. Mobilization of preformed cellular stores of inflammatory cytokines such as in mucosal mast cells may play an important pathophysiological role in ECMO-related SIRS. 2009-11-09 2010-01 /pmc/articles/PMC2799549/ /pubmed/19901912 http://dx.doi.org/10.1038/labinvest.2009.119 Text en Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
McILwain, Britt
Timpa, Joseph
Kurundkar, Ashish R.
Holt, David W.
Kelly, David R.
Hartman, Yolanda
Neel, Mary Lauren
Karnatak, Rajendra K.
Schelonka, Robert L.
Anantharamaiah, G. M.
Killingsworth, Cheryl R.
Maheshwari, Akhil
Plasma Concentrations of Inflammatory Cytokines Rise Rapidly during ECMO-related SIRS due to the Release of Pre-formed Stores in the Intestine
title Plasma Concentrations of Inflammatory Cytokines Rise Rapidly during ECMO-related SIRS due to the Release of Pre-formed Stores in the Intestine
title_full Plasma Concentrations of Inflammatory Cytokines Rise Rapidly during ECMO-related SIRS due to the Release of Pre-formed Stores in the Intestine
title_fullStr Plasma Concentrations of Inflammatory Cytokines Rise Rapidly during ECMO-related SIRS due to the Release of Pre-formed Stores in the Intestine
title_full_unstemmed Plasma Concentrations of Inflammatory Cytokines Rise Rapidly during ECMO-related SIRS due to the Release of Pre-formed Stores in the Intestine
title_short Plasma Concentrations of Inflammatory Cytokines Rise Rapidly during ECMO-related SIRS due to the Release of Pre-formed Stores in the Intestine
title_sort plasma concentrations of inflammatory cytokines rise rapidly during ecmo-related sirs due to the release of pre-formed stores in the intestine
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2799549/
https://www.ncbi.nlm.nih.gov/pubmed/19901912
http://dx.doi.org/10.1038/labinvest.2009.119
work_keys_str_mv AT mcilwainbritt plasmaconcentrationsofinflammatorycytokinesriserapidlyduringecmorelatedsirsduetothereleaseofpreformedstoresintheintestine
AT timpajoseph plasmaconcentrationsofinflammatorycytokinesriserapidlyduringecmorelatedsirsduetothereleaseofpreformedstoresintheintestine
AT kurundkarashishr plasmaconcentrationsofinflammatorycytokinesriserapidlyduringecmorelatedsirsduetothereleaseofpreformedstoresintheintestine
AT holtdavidw plasmaconcentrationsofinflammatorycytokinesriserapidlyduringecmorelatedsirsduetothereleaseofpreformedstoresintheintestine
AT kellydavidr plasmaconcentrationsofinflammatorycytokinesriserapidlyduringecmorelatedsirsduetothereleaseofpreformedstoresintheintestine
AT hartmanyolanda plasmaconcentrationsofinflammatorycytokinesriserapidlyduringecmorelatedsirsduetothereleaseofpreformedstoresintheintestine
AT neelmarylauren plasmaconcentrationsofinflammatorycytokinesriserapidlyduringecmorelatedsirsduetothereleaseofpreformedstoresintheintestine
AT karnatakrajendrak plasmaconcentrationsofinflammatorycytokinesriserapidlyduringecmorelatedsirsduetothereleaseofpreformedstoresintheintestine
AT schelonkarobertl plasmaconcentrationsofinflammatorycytokinesriserapidlyduringecmorelatedsirsduetothereleaseofpreformedstoresintheintestine
AT anantharamaiahgm plasmaconcentrationsofinflammatorycytokinesriserapidlyduringecmorelatedsirsduetothereleaseofpreformedstoresintheintestine
AT killingsworthcherylr plasmaconcentrationsofinflammatorycytokinesriserapidlyduringecmorelatedsirsduetothereleaseofpreformedstoresintheintestine
AT maheshwariakhil plasmaconcentrationsofinflammatorycytokinesriserapidlyduringecmorelatedsirsduetothereleaseofpreformedstoresintheintestine